Business Description
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
ISIN : CNE100000130
Share Class Description:
HKSE:08049: Class HCompare
Compare
Traded in other countries / regions
08049.Hong KongJIL.Germany IPO Date
2001-05-24Description
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is a pharmaceutical company. It is engaged in the manufacturing and distribution of Chinese medicines and pharmaceutical products. The company sells medicines under the brand names: Changlong and Qing Tong. The group has only one business segment which is the manufacture and distribution of Chinese medicines. It derives revenue from operations in the PRC.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.15 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.4 | |||||
| Interest Coverage | 309.46 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.36 | |||||
| Beneish M-Score | -2.33 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.7 | |||||
| 3-Year EBITDA Growth Rate | 6.5 | |||||
| 3-Year EPS without NRI Growth Rate | 3.6 | |||||
| 3-Year FCF Growth Rate | 71 | |||||
| 3-Year Book Growth Rate | 0.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.45 | |||||
| 9-Day RSI | 31.16 | |||||
| 14-Day RSI | 36.66 | |||||
| 6-1 Month Momentum % | 37.8 | |||||
| 12-1 Month Momentum % | 6.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.66 | |||||
| Quick Ratio | 1.51 | |||||
| Cash Ratio | 0.9 | |||||
| Days Inventory | 165.97 | |||||
| Days Sales Outstanding | 120.12 | |||||
| Days Payable | 88.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -4.38 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.39 | |||||
| Operating Margin % | 18.92 | |||||
| Net Margin % | 17.71 | |||||
| FCF Margin % | 33.68 | |||||
| ROE % | 9.47 | |||||
| ROA % | 6.34 | |||||
| ROIC % | 12.61 | |||||
| ROC (Joel Greenblatt) % | 66.55 | |||||
| ROCE % | 12.18 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.4 | |||||
| PE Ratio without NRI | 5.4 | |||||
| Price-to-Owner-Earnings | 2.84 | |||||
| PEG Ratio | 1.86 | |||||
| PS Ratio | 0.95 | |||||
| PB Ratio | 0.54 | |||||
| Price-to-Tangible-Book | 0.56 | |||||
| Price-to-Free-Cash-Flow | 2.82 | |||||
| Price-to-Operating-Cash-Flow | 2.55 | |||||
| EV-to-EBIT | 1.1 | |||||
| EV-to-EBITDA | 1.1 | |||||
| EV-to-Revenue | 0.26 | |||||
| EV-to-FCF | 1.24 | |||||
| Price-to-Projected-FCF | 0.31 | |||||
| Price-to-DCF (Earnings Based) | 0.47 | |||||
| Price-to-DCF (FCF Based) | 0.09 | |||||
| Price-to-Median-PS-Value | 0.91 | |||||
| Price-to-Graham-Number | 0.37 | |||||
| Price-to-Net-Current-Asset-Value | 2.21 | |||||
| Earnings Yield (Greenblatt) % | 90.91 | |||||
| FCF Yield % | 35.33 | |||||
| Forward Rate of Return (Yacktman) % | 18.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 922.754 | ||
| EPS (TTM) (HK$) | 0.291 | ||
| Beta | 0.22 | ||
| Volatility % | 51.02 | ||
| 14-Day RSI | 36.66 | ||
| 14-Day ATR (HK$) | 0.079059 | ||
| 20-Day SMA (HK$) | 1.732 | ||
| 12-1 Month Momentum % | 6.71 | ||
| 52-Week Range (HK$) | 1.07 - 2.05 | ||
| Shares Outstanding (Mil) | 560.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Frequently Asked Questions
What is Jilin Province Huinan Changlong Bio-pharmacy Co Ltd(HKSE:08049)'s stock price today?
The current price of HKSE:08049 is HK$1.57. The 52 week high of HKSE:08049 is HK$2.05 and 52 week low is HK$1.07.
When is next earnings date of Jilin Province Huinan Changlong Bio-pharmacy Co Ltd(HKSE:08049)?
The next earnings date of Jilin Province Huinan Changlong Bio-pharmacy Co Ltd(HKSE:08049) is .
Does Jilin Province Huinan Changlong Bio-pharmacy Co Ltd(HKSE:08049) pay dividends? If so, how much?
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd(HKSE:08049) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers